FUTURA MEDICAL PLC

Insiders Futura Medical plc

Equities

FUM

GB0033278473

Market Closed - London S.E. Other stock markets 16:35:09 14/05/2024 BST			5-day change	1st Jan Change
40 ^GBX	+0.76%		-1.48%	+56.86%

04-10	Futura Medical hails results as erectile dysfunction drug drives sales	AN
04-10	Transcript : Futura Medical plc, 2023 Earnings Call, Apr 10, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Futura Medical plc Announces Appointment of Roy Davis as Non-Executive Director	01-09	CI
Futura Medical chair steps down, promotes non-executive director	18/07/23	AN
Futura Medical Appoints Nonexecutive Chairman	18/07/23	MT
Futura Medical plc Announces Board Changes	18/07/23	CI
Futura Medical Announces its Topical Gel Formulation for the Treatment of Erectile Dysfunction (ED), MED3000, Under the Brand Name Eroxon®?, Is Now Available for Purchase in the UK	18/04/23	CI
Futura Medical plc Announces Board Appointment, Effective 1 January 2022	28/10/21	CI
Futura Medical plc Appoints Jeff Needham to the Board as aNon-Executive Director	08/10/21	CI
Futura Medical plc Announces Jonathan Freeman to Step Down as Senior Independent Non-Executive Director	29/09/21	CI
Futura Medical plc Announces Management Changes	20/02/18	CI
Futura Medical plc Appoints Ken James as an Executive Director and Head of R&D	16/11/16	CI
Lisa Arnold Decides to Step Down from Futura Medical plc as Non-Executive Director	15/03/16	CI
Futura Medical plc Appoints Ken James as Non-Executive Director, Effective from 31 March 2016	07/03/16	CI
Futura Medical plc Announces Appointment of CRO for MED2002 Clinical Study	15/12/14	CI
David Davies to Leave as Director of Futura Medical plc	13/11/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer